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Background: Endometrial cancer (EC) is the most frequently diagnosed gynecological malignancy and the fourth
most common cancer diagnosis overall among women. As with many other forms of cancer, it has been shown
that certain miRNAs are differentially expressed in EC and these miRNAs are believed to play important roles as
regulators of processes involved in the development of the disease. With the rapidly growing number of studies of
miRNA expression in EC, there is a need to organize the data, combine the findings from experimental studies of
EC with information from various miRNA databases, and make the integrated information easily accessible for the
EC research community.
Findings: The miREC database is an organized collection of data and information about miRNAs shown to be
differentially expressed in EC. The database can be used to map connections between miRNAs and their target
genes in order to identify specific miRNAs that are potentially important for the development of EC. The aim of the
miREC database is to integrate all available information about miRNAs and target genes involved in the
development of endometrial cancer, and to provide a comprehensive, up-to-date, and easily accessible source of
knowledge regarding the role of miRNAs in the development of EC. Database URL: http://www.mirecdb.org.
Conclusions: Several databases have been published that store information about all miRNA targets that have
been predicted or experimentally verified to date. It would be a time-consuming task to navigate between these
different data sources and literature to gather information about a specific disease, such as endometrial cancer. The
miREC database is a specialized data repository that, in addition to miRNA target information, keeps track of the
differential expression of genes and miRNAs potentially involved in endometrial cancer development. By providing
flexible search functions it becomes easy to search for EC-associated genes and miRNAs from different starting
points, such as differential expression and genomic loci (based on genomic aberrations).
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Background
Endometrial cancer is the most common cancer of the re-
productive tract in women in developed countries. Ac-
cording to the World Cancer Research Fund (WCRF)
around 288 000 women worldwide develop endometrial
cancer annually and 74 000 died from this cancer in 2008
[1]. It has been shown in several studies that a number of
microRNAs (miRNAs) are differentially expressed in EC
tumors compared to healthy endometrial tissue [2-9].* Correspondence: benjamin.ulfenborg@his.se
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unless otherwise stated.MiRNAs are small RNA molecules that regulate gene ex-
pression by inhibition of translation or by degradation of
their target mRNAs [10-12]. It has been shown that miR-
NAs play key roles in biological processes of relevance for
cancer, such as development, differentiation, cell prolifera-
tion, apoptosis and stress response [13], and it has been
estimated that up to 30% of human genes are regulated by
miRNAs [14]. Distinct expression signatures have been
found for practically every form of cancer in which
miRNA expression has been studied [14].
Several studies have identified miRNAs, which are dif-
ferentially expressed in EC compared to healthy endo-
metrial tissue. For example, miR-205 was found to be
over-expressed in EC by a number of authors [2,4-6]
and has also been described to be upregulated in bladderral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Data extraction from literature and databases. From
the literature, miRNAs and genes that were reported as deregulated
in EC were extracted, along with target genes (predicted and
verified) of these miRNAs, as listed in the articles. For the miRNAs
identified from the literature, the set of target genes was expanded
with verified targets found in miRecords and TarBase, Similarly, for
the genes identified from the literature, additional verified miRNA
regulators were downloaded from miRecords and TarBase.
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cancer [17]. The miR-200 family consists of five mem-
bers (miR-200a, 200b, 200c, 141 and 429), which have all
been shown to be upregulated in endometrial cancer
[5,9,18]. Furthermore, the members of the miR-200 fam-
ily together with miR-205 regulate the expression of tar-
get genes ZEB1 and ZEB2, which have been implicated
to be involved in epithelial to mesenchymal transition
and tumor progression [19]. Previous studies have also
shown that members of the miR-96 cluster (hsa-miR-96,
hsa-miR-182 and hsa-miR-183) are upregulated in endo-
metrial cancer [5,6,18,20]. More recently, the downregu-
lation of miR-199a-3p in EC has been reported. This
miRNA was found to inhibit tumor proliferation by sup-
pression of mTOR [21]. Another study identified three
miRNAs (miR-499, miR-135b and miR-205) as upregu-
lated and five (miR-10b, miR-195, miR-30a-5p, miR-30a-
3p and miR-21) as downregulated [22]. Apart from these
prominent examples, many other miRNAs with EC-
associated expression patterns have been identified. For
example, Chung et al. [2] identified 30 miRNAs which
were significantly deregulated in EC tumor samples,
while Boren et al. [3] found 13, Weiguang et al. [5]
found 23 and Cohn et al. [4] found 15 in early stage EC
tumors and 18 in late stage tumors. Furthermore, Torres
et al. [7] identified 21 dysregulated miRNAs from 122
samples, Zhang et al. [23] found 47 miRNAs from 73
samples, and Jurcevic et al. identified 138 miRNAs from
50 samples as differentially expressed between normal
and tumor endometrium [18]. The wealth of EC-related
miRNA data in the literature clearly demonstrate the
need to collect information about all implicated miR-
NAs, since different studies may reflect different disease
stages, patient subgroups, experimental methods, etc.
Studying the roles of miRNAs in a complex disease such
as EC requires integration of data from several sources,
including miRNA databases, miRNA target databases, gene
annotation databases, expression data repositories and bio-
medical literature. To facilitate the integration of data and
information from various sources, we developed the miREC
(miRNAs in Endometrial Cancer) database, which stores in-
formation about miRNAs experimentally shown to be aber-
rantly expressed in EC. The database also contains the genes
that have been identified as targets of these miRNAs by pre-
diction software or by experiments (or both). By storing the
connections between EC-associated miRNAs and their com-
putationally predicted and/or experimentally verified target
genes, miREC provides a systematic overview of miRNA-
regulation of processes involved in EC development. This
information can be downloaded and visualized as a network
using the Cytoscape [24] software. The miREC database is,
to the best of our knowledge, the first systematic effort to
integrate all available information about miRNAs and
miRNA-targeted genes associated with endometrial cancer.Data sources
The miRNAs and their target genes were extracted from
the studies of EC in H. sapiens which have been published
to date [2-9,20,25-27]. The criteria used for miRNAs and
genes to qualify for inclusion in miREC were the same as
each author used for identifying significant deregulation
(see Additional file 1: Table S1). Using a single criterion
for all datasets was not feasible, since the studies were
done using different experimental techniques (qRT-PCR
or microarray), sample sizes, numbers of probes, etc., and
since not all raw datasets were available. Applying the cri-
teria resulted in extraction of 186 miRNAs and 576 genes
shown experimentally to be deregulated in EC. In silico
predicted and experimentally verified connections be-
tween miRNAs and target genes were also extracted to
the extent that they appeared in the articles (275 predicted
and 879 experimentally verified connections).
In addition to extracting data from the EC literature,
information was also retrieved from the miRNA target
databases miRecords and TarBase [28,29]. These data-
bases contain experimentally verified regulator-target
relationships between miRNAs and genes, and provide
vital information to the understanding of the biological
functions of miRNAs. MiRNAs and genes falling into
the following two categories were extracted: (i) Genes
that have been experimentally verified as targets of miR-
NAs that have been identified as deregulated in EC (344
genes); (ii) miRNAs that have been experimentally
verified as targeting genes that have been identified as
deregulated in EC (42 miRNAs). This raised the total
number of miRNAs and target genes in miREC to 228
and 920, respectively. The miRecords version used was
the 25th November 2010 update, and the TarBase ver-
sion was 5.0. The scheme for information retrieval and
storage in miREC is illustrated in Figure 1.
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and TarBase was complemented by information extracted
from miRBase and the HUGO Gene Nomenclature
Committee’s database (HGNC) [30,31], including gene
names, IDs and symbols for genes and miRNAs, miRBase
accession numbers and genome loci. The naming scheme
for genes and miRNAs in miREC follows the HGNC
nomenclature.Implementation
The miREC database was implemented as a relational data-
base in mySQL on an Apache web server. A web interface
was created using PHP to enable data input and searching
in a user-friendly environment. The database is available
online at http://www.mirecdb.org.Overview of database contents and structure
The current version of the database contains 228 miR-
NAs and 920 target genes. This may be contrasted with
the number of human miRNAs in other data repositor-
ies such as microCosm, PhenomiR [32] and miR2Disease
[33]. Compared to these databases, miREC is specialized
towards miRNAs in endometrial cancer, which means
that our database contains a smaller subset of all known
miRNAs. This will allow the EC research community to
find EC-specific information more easily. Of the entries
in miREC, 186 miRNAs and 576 target genes come from
published literature and the remaining ones from miRe-
cords and TarBase. The aim of building the database
was to facilitate a further understanding of EC develop-
ment and provide a resource that will help identify
miRNAs that can be evaluated for potential usage as
markers for classification, diagnosis and prognosis. The
information stored in the database includes:
 target genes and miRNAs;
 relations between miRNAs and their target genes;
 references to published scientific articles; and
 literature citations for genes, miRNAs and gene-
miRNA relations.
For both target genes and miRNAs, the database stores
the name, symbol, HGNC ID, organism, chromosome
positions, type of deregulation in EC (up- or downregulated,
or unspecified), and verification status of the deregulation.
For miRNAs, the miRBase accession number is also stored.
The citation tables keep track of the literature sources where
information about miRNAs, target genes, and miRNA-
target gene relations was found. This allows the full article
references to be displayed on the information pages for each
miRNA and target gene entry. The information in miRNA
and target gene entries is complemented with links to other
databases.Querying the database
A wide range of search options is available via the web
interface, allowing the user to search the database for
genes, miRNAs and regulatory relationships. The main
page presents a Quick Search option, while advanced
search options can be found through the menu. Quick
search has two options: search by gene and search by
miRNA. Figure 2 shows an example quick search for
miRNAs and how the results are displayed as a table in
the web browser (Figure 2A). This table may contain a
number of different miRNAs or genes, as all database
entries that contain the query text in the name, symbol
or accession number will be retrieved. By clicking the
miRNA name in the result list, a page with more detailed
information about the miRNA will be displayed (Figure 2B),
including links to external databases (miRBase and HGNC)
with additional annotation, the observed form of deregula-
tion in cancer (up- or downregulated) and the verification
status of the deregulation (experimentally verified or not), a
list of predicted and/or experimentally verified gene targets
(Figure 2C), and a list of publications serving as references
for the information with links to their PubMed entries.
From the page shown in Figure 2C it is possible to go
to the information page of each target gene. Thereby the
user can get information about other miRNAs that regu-
late the same target gene. The lists of target genes and
regulating miRNAs can be filtered by using the verifica-
tion and deregulation options, so that, for example, only
downregulated target genes are shown. Many more
options are available in the advanced search forms. For
example, it is possible to search for all genes targeted by
a specific miRNA, or to search for all miRNAs targeting
a specific gene. Many different searches are possible by
setting combinations of parameter values. For example,
specifying hsa-mir-106a as regulator, setting the option
“Number of regulators” to “3” and the option “Verifica-
tion of regulator connections” to “Verified”, the result
would only include genes which have been experimen-
tally shown to be regulated by hsa-mir-106a and at least
two other miRNAs.
The results of a search for all genes regulated by hsa-miR-
106a are shown in Figure 3A. This miRNA has been identi-
fied as dysregulated in EC in three studies [2,3,18]. To
visualize the results, a gene-miRNA interaction network can
be downloaded using the links above the results table. The
network is in the Simple Interaction Format (SIF) and can
be imported and viewed in the free Cytoscape software [24].
Supplementary node and edge attribute files can also be
downloaded and imported into Cytoscape to enrich the
visualization with information for all genes, miRNAs and
connections. Figure 3B shows a network generated from the
search results of Figure 3A. Such visualizations integrate dif-
ferent pieces of information regarding the genes/miRNAs of
interest and make it easier to formulate research questions
Figure 2 Result from Quick Search on hsa-mir-200a. (A) Results of a quick search for the miRNA hsa-mir-200a. (B) More detailed page with information
relating to the same microRNA. The contents of this page are divided into three sections: (1) miRNA information, including alias, symbol, accession number,
organism, HGNC ID, chromosome location, form of deregulation, deregulation verification status and references; (2) Gene Targets, showing target genes,
verification status of each miRNA-target association, and references; (3) Articles, showing a detailed list of references, including links to PubMed entries
(not shown in the figure).
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plified in the next chapter.
Identifying miRNA clusters
The network in Figure 3B shows that hsa-mir-106a along
with three other miRNAs (hsa-mir-17; hsa-mir-19b-2 and
hsa-mir-27a) have verified connections (thick edges) to a
number of genes. Two of these genes are HIPK3 and
MYLIP, which are regulated by hsa-mir-106a and hsa-mir-
19b-2. Two other genes, RUNX1 and CDKN1A, are regu-
lated by hsa-mir-106a and hsa-mir-17. A literature search
showed that two of these miRNAs, namely hsa-mir-106a
and hsa-mir-19b-2, belong to the same miRNA cluster on
human chromosome X. Furthermore, this cluster is a para-
log of the mir17 cluster on chromosome 13, in which hsa-
mir-17 is located. Specifically, hsa-mir-106a is a homolog to
hsa-mir-17 [34]. This demonstrates how a database query
in miREC, followed by analysis of the resulting network,
leads to identification of a functional relationship between
miRNAs that belong to the same or related clusters in the
genome. In this particular example, the part of the network
analyzed in this paragraph corresponds to information
gathered from four different articles, which is easily identifi-
able in the visualization.
Clustered miRNAs share target genes
The miREC database can also be used to analyze whether
there is a general tendency for miRNAs located in the
same clusters to share target genes. To investigate this,the number of common target genes for pairs of miRNAs
located in the same cluster was compared to the number
of common targets for pairs of miRNAs not located in the
same cluster (Figure 4). A search for all miRNAs in
miREC with verified target genes identified 169 miRNAs
with a total of 792 targets (average 4.69). Using a distance
limit of 10 000 nucleotides, 74 of these miRNAs were
found to reside in 30 clusters, of which 21 clusters with
two miRNAs each, six with three miRNAs each, two with
four miRNAs each and one cluster with six miRNAs.
Thus, we could form 66 pairs of miRNAs where both were
located in the same cluster. The remaining 95 miRNAs
were labeled as “distant miRNAs”. The average number of
target genes was 10.3 and 12.5 for clustered and distant
miRNAs, respectively.
The number of shared targets was then counted for
the 66 pairs of miRNAs located in the same clusters and
for all 4,465 pairs of distant miRNAs. It was found that
the 66 clustered pairs of miRNAs had 175 common tar-
gets while the pairs of distant miRNAs had 947 common
targets, i.e. an average of 2.65 versus an average of 0.21.
Seventeen of the pairs of distant miRNAs were formed
between duplicates (e.g. hsa-mir-1-1 and hsa-mir-1-2),
which have identical sequences and therefore obviously
identical sets of target genes. When these duplicate
pairs, which had 692 target genes in common (40.7 on
average) were removed from the analysis, the average
number of shared targets for pairs of distant miRNAs
dropped to 0.06.
Figure 3 Demonstration of advanced search. (A) Results from a search for genes with hsa-mir-106a as miRNA regulator (without restrictions on
verification status or number of regulators). (B) Network generated from the same search, showing hsa-mir-106a (yellow triangle), four of its target genes
(green nodes) and other miRNAs targeting these genes (pink nodes). Triangles indicate up-regulation in cancer, V shapes indicate down-regulation and
squares indicate that there is no experimental data on expression in EC. Edges indicate gene-miRNA relationships, with thick black edges indicating verified
regulation. The network can be downloaded using the SIF hyperlink under the heading Human Graph above the results table in Figure 3A.
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clustered pairs of miRNAs shared more than 12 times
as many target genes as pairs of distant miRNAs. This
indicates that the clustering of miRNAs in genomes
throughout evolution is important for the regulation of
transcription. It seems reasonable that clustered miR-
NAs can more easily be co-regulated and thus function
as a regulatory unit, thereby coordinately affecting the
activity of the biological processes in which their shared
target genes are involved. Interestingly, a recent study
by Sass et al. [35] provides evidence of co-expressed
miRNAs (including clustered miRNAs) targeting differ-
ent components in the same protein complex. Other
authors have shown that the genomic organization of
some miRNA clusters have been preserved over millions
of years of evolution, which indicates a functional ad-
vantage of this arrangement [36]. That clustering facili-
tates coordinated regulation of components, both in
protein complexes and in pathways, may be the explan-
ation for the tendency for this genomic organization to
be preserved.Enabling cancer hallmarks in endometrial cancer through
miRNA dysregulation
It is recognized that, in order for tumors to develop,
cells must acquire cellular characteristics that are very
different from those of healthy cells. These characteris-
tics are referred to as cancer hallmarks and give tumor
cells an evolutionary advantage over normal cells e.g. in
terms of growth and proliferation [37]. Therefore, to
understand tumorigenesis, the acquisition of these can-
cer hallmarks must be studied in different tumors. Since
individual miRNAs have potentially hundreds of target
genes, miRNA dysregulation will have a profound effect
on the regulation of the cellular machinery and contrib-
ute to enabling cancer hallmarks. To study this for EC,
all miRNAs experimentally shown to be dysregulated in
endometrial cancer were downloaded from miREC,
along with their experimentally verified target genes (93
miRNAs and 472 genes). As an example of how to study
the biological annotation for the genes in miREC, the
gene list was submitted to DAVID and annotation en-
richment analysis was carried out by inspecting terms
Figure 4 Comparison of verified target gene sets for pairs of
clustered miRNAs versus pairs of distant miRNAs. The two
miRNAs hsa-mir-200a and hsa-mir-429 are located <10,000 bp from
each other on chromosome 1 and thus belong to the same cluster.
Two other miRNAs, hsa-mir-9-1 and hsa-mir-205, are not within the
distance limit and thus considered distant. While hsa-mir-200a (with
11 targets) and hsa-mir-429 (with 10 targets) have seven targets in
common, the distant pair hsa-mir-9-1 and hsa-mir-205 (with seven
targets each) do not have any target genes in common.
Figure 5 Significantly enriched gene annotation among the verified targe
p-values. Panel A: Enriched KEGG pathways. Panel B: Enriched biological processe
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results clearly demonstrate a significant enrichment of
cancer-specific pathways and pathways frequently altered
in cancer (Figure 5A), such as MAPK, ErbB, p53, Toll-like
receptor and VEGF signaling pathways. TFG-β, mTOR
and Wnt signalling pathways were also enriched (data not
shown). Several significant biological processes related to
cancer hallmarks were detected, including regulation of
cell proliferation, cell death, metabolic processes, tran-
scription, differentiation and immune system development
(Figure 5B). Enrichment was also seen for cell adhesion,
cell motion and angiogenesis GO terms (data not shown).
To visualize the miRNA-mediated regulation of these
genes, a network of the genes and miRNAs was also
downloaded from miREC (Figure 6). The genes were
annotated with terms from the biological process and mo-
lecular function hierarchies of Gene Ontology. To reduce
the granularity of terms and more effectively highlight
cancer hallmark genes in the network, the following pro-
cedure was used. First, annotation terms assigned to the
genes were downloaded, including the following terms
and their respective child terms: cell proliferation, cell
growth, cell death, angiogenesis, cell cycle, cell differenti-
ation, telomerase activity, telomere maintenance, cell
adhesion, cell motility and DNA repair. Second, all child
terms were replaced with their parent term from the first
step. Third, the terms of the genes were propagated to
their regulator miRNAs. The resulting network (Figure 6)
contains 295 genes and 93 miRNAs. Since many genest genes. Significance level was set to 0.05 for Benjamini-Hochberg-corrected
s.
Figure 6 Network of dysregulated miRNAs and their target genes annotated with biological processes. Genes are indicated by small squares
and miRNAs are large circles. Processes are colored as followed: Cell growth (yellow), cell proliferation (green), cell death (black), DNA repair (dark green),
telomerase activity and telomere maintenance (light blue), angiogenesis (purple), cell differentiation (red), cell cycle (teal) and cell adhesion/motility
(dark blue).
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was created for every term of a given gene or miRNA. The
resulting network highlights the importance of key miR-
NAs, such as the central location of hsa-miR-34a in the
cell proliferation and differentiation sub-networks [38,39].
This network allows detailed analysis of regulatory mech-
anisms by miRNAs involved in endometrial cancer hall-
marks (Additional file 2). As an example, hsa-miR-125b,
hsa-miR-146 and hsa-miR-27b regulate three genes in-
volved in telomerase activity and telomere maintenance
(HIST1H4A, POLE2 and PPARG). HIST1H4A is involved
in telomere maintenance and is regulated by hsa-miR-125b
(experimentally supported). Although hsa-miR-125b is
downregulated in EC tumors, the expression of HIST1H4A
in EC has not been reported in the literature. By suppress-
ing hsa-miR-125b, HIST1H4A could be upregulated allow-
ing the tumor to stabilize its telomeres. Furthermore,
PPARG is a negative regulator of telomerase activity and is
itself regulated by hsa-miR-27b, which is upregulated in
EC. PPARG upregulation at the mRNA level has been
reported in the literature [40,41], but the protein is down-
regulated in tumors [41]. Thus hsa-miR-27b may prevent
translation of PPARG mRNA and allow tumors to prevent
suppression of telomerase; further supporting telomere
stabilization to enable replicative immortality. However,POLE2 is also involved in telomere maintenance and is
regulated by hsa-miR-146, which is upregulated in EC.
This appears to oppose replicative immortality, which
reveals the complexity of miRNA-mediated regulation.
This complexity is further highlighted by the fact that the
miRNAs in Figure 6 regulate five biological processes on
average. The number of processes per gene and miRNA is
shown in Figure 7. The question of how EC tumors enable
immortality clearly presents a potential future direction in
EC research. The miREC database allows researchers to
identify both miRNAs and genes of interest based on
high-confidence data.
Conclusions
The miREC database was created to provide information
about miRNAs and genes that are potentially involved in
the development of endometrial cancer. There are sev-
eral general databases that contain information about
miRNAs and their target genes, such as miRecords. In
contrast, miREC focuses on data that is specific for EC,
which makes it easier for researchers to derive disease-
specific information, e.g. miRNA-target interaction net-
works including only those miRNAs that are deregulated
in EC. The wide range of search functions in miREC
makes it possible to find EC-associated miRNAs from
Figure 7 Number of biological processes per gene and miRNA.
Panel A: Number of processes associated with genes. Panel B:
Number of processes associated with miRNAs.
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of deregulation, genomic location, etc.
By analyzing data from the miREC database, it was found
that the number of common target genes was significantly
higher for pairs of miRNAs located in the same cluster com-
pared to random pairs of distant miRNAs. Recent studies
have shown that clustered miRNAs are often co-expressed
and often transcribed as polycistrons [36,42], and it has been
suggested that this supports coordinated miRNA regulation
of protein complexes and target pathways [36,43]. The result
from the analysis on common targets of clustered miRNAs
presented here also supports this hypothesis. Furthermore,
since miRNAs regulate genes involved in several cancer hall-
marks, the dysregulation of miRNAs will allow tumors to
acquire several characteristics necessary for tumorigenesis.
The database is very general and contains data from all
published studies found in the literature survey. Using the
search functions subsets of genes and miRNAs of interest
can be downloaded for analysis to test hypotheses of interest
to the user. It is then important to apply suitable quality
control, since the data was collected from studies using
different experimental techniques, sample sizes, numbers of
probes, etc. Furthermore, biopsies from which RNA is
extracted may contain heterogeneous cell populations with
respect to cell type, tumor stage, etc. This may con-
found statistical analysis and interfere with measuringgene expression in tumor cells [44]. Since the aim of the
literature survey was to collect all studies of gene and
miRNA deregulation in EC, the risk of confounded re-
sults was not investigated further.
The miRNA data will in future versions of the database
be complemented with additional layers of disease infor-
mation, such as gene and protein expression, genome al-
terations and epigenetic patterns, to establish a more
general platform for EC research. The database is designed
to allow organism-specific information to be added, which
means that information obtained from animal models can
be used to complement the information from human. In
future updates of the miREC database, results derived
from a rat model of EC [45] will be added to enable com-
parative mapping of miRNAs. Due to the high degree of
conservation between human and rat, the information
from the rat experiments can easily be extrapolated to hu-
man. Finally, results from the rat model experiments will
be used in our efforts to derive a miRNA expression signa-
ture for EC diagnosis in humans.
Availability and requirements
Project name: miREC database





Any restrictions to use by non-academics: None
Additional files
Additional file 1: Table S1. Curated Studies: Table containing
published studies in the literature from which data in the miREC
database have been curated.
Additional file 2: Annotation network: Network created in
Cytoscape using miRNAs and genes downloaded from miREC
version 2 and Gene Ontology annotation.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
BO and KKL conceived of the study. BU and SJ curated and analyzed data
included in the database. BU and AL designed the database structure. BU,
SJ, BO, KKL participated in preparing the draft of the manuscript. All authors
read and approved the final manuscript.
Acknowledgements
This work was supported by the Swedish Knowledge Foundation, [grant
number 2009/091]. The web design was performed by Mindius AB, Skövde.
Author details
1Systems Biology Research Centre – Bioinformatics, University of Skövde, Box
408, 541 28 Skövde, Sweden. 2Systems Biology Research Centre – Tumor
Biology, University of Skövde, Box 408, 54128 Skövde, Sweden.
Received: 2 December 2014 Accepted: 11 March 2015
Ulfenborg et al. BMC Research Notes  (2015) 8:104 Page 9 of 9References
1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of
worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer.
2010;127:2893–917.
2. Chung TKH, Cheung T-H, Huen N-Y, Wong KWY, Lo KWK, Yim S-F, et al.
Dysregulated microRNAs and their predicted targets associated with
endometrioid endometrial adenocarcinoma in Hong Kong women. Int J
Cancer. 2009;124:1358–65.
3. Boren T, Xiong Y, Hakam A, Wenham R, Apte S, Wei Z, et al. MicroRNAs and
their target messenger RNAs associated with endometrial carcinogenesis.
Gynecol Oncol. 2008;110:206–15.
4. Cohn D, Fabbri M, Valeri N, Alder H, Ivanov I, Liu C, et al. Comprehensive
miRNA profiling of surgically staged endometrial cancer. Am J Obstet
Gynecol. 2010;202:656. e-656.e658.
5. Wu W, Lin Z, Zhuang Z, Liang X. Expression profile of mammalian
microRNAs in endometrioid adenocarcinoma. Eur J Cancer Prev.
2009;18:50–5.
6. Ratner ES, Tuck D, Richter C, Nallur S, Patel RM, Schultz V, et al. MicroRNA
signatures differentiate uterine cancer tumor subtypes. Gynecol Oncol.
2010;118:251–7.
7. Torres A, Torres K, Pesci A, Ceccaroni M, Paszkowski T, Cassandrini P, et al.
Diagnostic and prognostic significance of miRNA signatures in tissues and
plasma of endometrioid endometrial carcinoma patients. Int J Cancer.
2013;132:1633–45.
8. Liu X, Xia W, Dai YM, Shao NS, Zhang WY. [Expression of microRNAs in
endometrioid adenocarcinoma]. Zhonghua Yi Xue Za Zhi / Chin J Med
Genetics. 2009;89:1365–7.
9. Lee JW, Park YA, Choi JJ, Lee YY, Kim CJ, Choi C, et al. The expression of the
miRNA-200 family in endometrial endometrioid carcinoma. Gynecol Oncol.
2011;120:56–62.
10. Hutvagner G, McLachlan J, Pasquinelli A, Balint E, Tuschl T, Zamore P. A
cellular function for the RNA-interference enzyme Dicer in the maturation
of the let-7 small temporal RNA. Sci STKE. 2001;293:834.
11. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, et al. The nuclear RNase III Drosha
initiates microRNA processing. Nature. 2003;425:415–9.
12. Lee Y, Jeon K, Lee J, Kim S, Kim V. MicroRNA maturation: stepwise
processing and subcellular localization. EMBO J. 2002;21:4663–70.
13. Blenkiron C, Miska E. miRNAs in cancer: approaches, aetiology, diagnostics
and therapy. Hum Mol Genet. 2007;16:R106.
14. Stahlhut ECE, Slack F. The role of microRNAs in cancer. Yale J Biol Med.
2006;79:131.
15. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, et al. Micro-RNA
profiling in kidney and bladder cancers. Urol Oncol. 2007;25:387–92.
16. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, et al.
MicroRNA signatures in human ovarian cancer. Cancer Res. 2007;67:8699.
17. Sempere LF, Christensen M, Silahtaroglu A, Bak M, Heath CV, Schwartz G,
et al. Altered MicroRNA expression confined to specific epithelial cell
subpopulations in breast cancer. Cancer Res. 2007;67:11612–20.
18. Jurcevic S, Olsson B, Klinga-Levan K. MicroRNA expression in human
endometrial adenocarcinoma. Cancer Cell Int. 2014;14:88.
19. Park SM, Gaur AB, Lengyel E, Peter ME. The miR-200 family determines the
epithelial phenotype of cancer cells by targeting the E-cadherin repressors
ZEB1 and ZEB2. Genes Dev. 2008;22:894–907.
20. Myatt SS, Wang J, Monteiro LJ, Christian M, Ho KK, Fusi L, et al. Definition of
microRNAs that repress expression of the tumor suppressor gene FOXO1 in
endometrial cancer. Cancer Res. 2010;70:367.
21. Wu D, Huang H-j, He C-n, Wang K-y. MicroRNA-199a-3p regulates endometrial
cancer cell proliferation by targeting mammalian target of rapamycin (mTOR).
Int J Gynecol Cancer. 2013;23:1191–7.
22. Tsukamoto O, Miura K, Mishima H, Abe S, Kaneuchi M, Higashijima A, et al.
Identification of endometrioid endometrial carcinoma-associated microRNAs
in tissue and plasma. Gynecol Oncol. 2014;132:715–21.
23. Zhang X, Dong Y, Ti H, Zhao J, Wang Y, Li T, et al. Diagnostic and
prognostic significance of miRNA signatures in tissues and plasma of
endometrioid carcinomas. Hum Pathol. 2013;44:2571–80.
24. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al.
Cytoscape: a software environment for integrated models of biomolecular
interaction networks. Genome Res. 2003;13:2498–504.
25. Zhou J, Song T, Gong S, Zhong M, Su G. microRNA regulation of the
expression of the estrogen receptor in endometrial cancer. Mol Med Report.
2010;3:387–92.26. Chung TK, Lau TS, Cheung TH, Yim SF, Lo KW, Siu NS et al. Dysregulation of
microRNA-204 mediates migration and invasion of endometrial cancer by
regulating FOXC1. In Book Dysregulation of microRNA-204 mediates
migration and invasion of endometrial cancer by regulating FOXC1
(Editor ed.^eds.), 2011/03/15 edition. City; 2011.
27. Wong YF, Cheung TH, Lo KW, Yim SF, Siu NS, Chan SC, et al. Identification
of molecular markers and signaling pathway in endometrial cancer in Hong
Kong Chinese women by genome-wide gene expression profiling.
Oncogene. 2007;26:1971–82.
28. Xiao F, Zuo Z, Cai G, Kang S, Gao X, Li T. miRecords: an integrated resource
for microRNA-target interactions. Nucleic Acids Res. 2009;37:D105–10.
29. Papadopoulos GL, Reczko M, Simossis VA, Sethupathy P, Hatzigeorgiou AG.
The database of experimentally supported targets: a functional update of
TarBase. Nucleic Acids Res. 2009;37:D155–8.
30. Lee SJ, Cicila GT. Functional genomics in rat models of hypertension: using
differential expression and congenic strains to identify and evaluate
candidate genes. Crit Rev Eukaryot Gene Expr. 2002;12:297–316.
31. Hanahan D, Coussens LM. Accessories to the crime: functions of cells
recruited to the tumor microenvironment. Cancer Cell. 2012;21:309–22.
32. Ruepp A, Kowarsch A, Schmidl D, Buggenthin F, Brauner B, Dunger I, et al.
PhenomiR: a knowledgebase for microRNA expression in diseases and
biological processes. Genome Biol. 2010;11:R6.
33. Jiang Q, Wang Y, Hao Y, Juan L, Teng M, Zhang X, et al. miR2Disease: a
manually curated database for microRNA deregulation in human disease.
Nucleic Acids Res. 2009;37:D98–104.
34. Tanzer A, Stadler PF. Molecular evolution of a microRNA cluster. J Mol Biol.
2004;339:327–35.
35. Sass S, Dietmann S, Burk UC, Brabletz S, Lutter D, Kowarsch A, et al.
MicroRNAs coordinately regulate protein complexes. BMC Syst Biol.
2011;5:136.
36. Ambros V. The evolution of our thinking about microRNAs. Nat Med.
2008;14:1036–40.
37. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell.
2011;144:646–74.
38. Li L, Yuan L, Luo J, Gao J, Guo J, Xie X. MiR-34a inhibits proliferation and
migration of breast cancer through down-regulation of Bcl-2 and SIRT1.
Clin Exp Med. 2013;13:109–17.
39. Aranha MM, Santos DM, Solá S, Steer CJ, Rodrigues CMP. miR-34a regulates
mouse neural stem cell differentiation. PLoS One. 2011;6:e21396.
40. Holland CM, Saidi SA, Evans AL, Sharkey AM, Latimer JA, Crawford RAF, et al.
Transcriptome analysis of endometrial cancer identifies peroxisome
proliferator-activated receptors as potential therapeutic targets. Mol Cancer
Ther. 2004;3:993–1001.
41. Knapp P, Chabowski A, Blachnio-Zabielska A, Jarzabek K, Wolczynski S.
Altered peroxisome-proliferator activated receptors expression in human
endometrial cancer. PPAR Res. 2012;2012:471524.
42. Baskerville S, Bartel DP. Microarray profiling of microRNAs reveals frequent
coexpression with neighboring miRNAs and host genes. RNA. 2005;11:241–7.
43. Zhang YF, Zhang R, Su B. Diversity and evolution of MicroRNA gene
clusters. Sci China Ser C Life Sci. 2009;52:261–6.
44. Kent OA, McCall MN, Cornish TC, Halushka MK. Lessons from miR-143/145:
the importance of cell-type localization of miRNAs. Nucleic Acids Res.
2014;42:7528–38.
45. Hamta A, Adamovic T, Helou K, Levan G. Cytogenetic aberrations in
spontaneous endometrial adenocarcinomas in the BDII rat model as
revealed by chromosome banding and comparative genome hybridization.
Cancer Genet Cytogenet. 2005;159:123–8.
